Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-31 @ 11:23 AM
Study NCT ID:
NCT05098028
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2021-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease
Sponsor:
Bausch Health Americas, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RBSC2161
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None